nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—CYP2A6—Methimazole—Graves' disease	0.249	0.282	CbGbCtD
Nifedipine—CYP2E1—Methimazole—Graves' disease	0.164	0.186	CbGbCtD
Nifedipine—CYP2B6—Methimazole—Graves' disease	0.162	0.183	CbGbCtD
Nifedipine—CYP1A2—Methimazole—Graves' disease	0.0951	0.108	CbGbCtD
Nifedipine—CYP2C9—Methimazole—Graves' disease	0.0857	0.0969	CbGbCtD
Nifedipine—CYP2D6—Methimazole—Graves' disease	0.0783	0.0886	CbGbCtD
Nifedipine—CYP3A4—Methimazole—Graves' disease	0.0498	0.0563	CbGbCtD
Nifedipine—Lymphadenopathy—Methimazole—Graves' disease	0.00364	0.0494	CcSEcCtD
Nifedipine—Lymphadenopathy—Propylthiouracil—Graves' disease	0.0031	0.042	CcSEcCtD
Nifedipine—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.0028	0.0379	CcSEcCtD
Nifedipine—Jaundice—Methimazole—Graves' disease	0.00233	0.0316	CcSEcCtD
Nifedipine—CACNA1S—thyroid gland—Graves' disease	0.0023	0.0549	CbGeAlD
Nifedipine—Agranulocytosis—Methimazole—Graves' disease	0.00223	0.0303	CcSEcCtD
Nifedipine—Hepatitis—Methimazole—Graves' disease	0.00215	0.0291	CcSEcCtD
Nifedipine—Jaundice—Propylthiouracil—Graves' disease	0.00198	0.0269	CcSEcCtD
Nifedipine—Agranulocytosis—Propylthiouracil—Graves' disease	0.0019	0.0257	CcSEcCtD
Nifedipine—Alopecia—Methimazole—Graves' disease	0.0019	0.0257	CcSEcCtD
Nifedipine—Haemoglobin—Propylthiouracil—Graves' disease	0.00184	0.0249	CcSEcCtD
Nifedipine—Hepatitis—Propylthiouracil—Graves' disease	0.00183	0.0248	CcSEcCtD
Nifedipine—Haemorrhage—Propylthiouracil—Graves' disease	0.00183	0.0248	CcSEcCtD
Nifedipine—KCNA1—thyroid gland—Graves' disease	0.00181	0.0432	CbGeAlD
Nifedipine—CACNA1H—pituitary gland—Graves' disease	0.0017	0.0406	CbGeAlD
Nifedipine—Vertigo—Methimazole—Graves' disease	0.00168	0.0228	CcSEcCtD
Nifedipine—CACNA1C—connective tissue—Graves' disease	0.00168	0.0401	CbGeAlD
Nifedipine—Leukopenia—Methimazole—Graves' disease	0.00167	0.0227	CcSEcCtD
Nifedipine—Alopecia—Propylthiouracil—Graves' disease	0.00161	0.0219	CcSEcCtD
Nifedipine—CACNB2—pituitary gland—Graves' disease	0.0016	0.0383	CbGeAlD
Nifedipine—Myalgia—Methimazole—Graves' disease	0.00159	0.0216	CcSEcCtD
Nifedipine—Arthralgia—Methimazole—Graves' disease	0.00159	0.0216	CcSEcCtD
Nifedipine—Dysgeusia—Propylthiouracil—Graves' disease	0.00156	0.0211	CcSEcCtD
Nifedipine—Oedema—Methimazole—Graves' disease	0.00153	0.0207	CcSEcCtD
Nifedipine—CACNA2D1—adipose tissue—Graves' disease	0.0015	0.0358	CbGeAlD
Nifedipine—Thrombocytopenia—Methimazole—Graves' disease	0.00149	0.0203	CcSEcCtD
Nifedipine—CACNA1H—thyroid gland—Graves' disease	0.00146	0.035	CbGeAlD
Nifedipine—CALM3—eye—Graves' disease	0.00146	0.0349	CbGeAlD
Nifedipine—Vertigo—Propylthiouracil—Graves' disease	0.00143	0.0194	CcSEcCtD
Nifedipine—Leukopenia—Propylthiouracil—Graves' disease	0.00142	0.0193	CcSEcCtD
Nifedipine—CACNA1D—pituitary gland—Graves' disease	0.0014	0.0335	CbGeAlD
Nifedipine—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00139	0.0189	CcSEcCtD
Nifedipine—CACNB2—thyroid gland—Graves' disease	0.00138	0.033	CbGeAlD
Nifedipine—Paraesthesia—Methimazole—Graves' disease	0.00137	0.0186	CcSEcCtD
Nifedipine—Somnolence—Methimazole—Graves' disease	0.00136	0.0184	CcSEcCtD
Nifedipine—Arthralgia—Propylthiouracil—Graves' disease	0.00135	0.0184	CcSEcCtD
Nifedipine—Myalgia—Propylthiouracil—Graves' disease	0.00135	0.0184	CcSEcCtD
Nifedipine—Dyspepsia—Methimazole—Graves' disease	0.00134	0.0182	CcSEcCtD
Nifedipine—Oedema—Propylthiouracil—Graves' disease	0.0013	0.0176	CcSEcCtD
Nifedipine—CACNA2D1—thyroid gland—Graves' disease	0.0013	0.031	CbGeAlD
Nifedipine—CACNA1C—pituitary gland—Graves' disease	0.00129	0.0309	CbGeAlD
Nifedipine—CACNA1C—adipose tissue—Graves' disease	0.00129	0.0308	CbGeAlD
Nifedipine—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00127	0.0172	CcSEcCtD
Nifedipine—CYP2A6—adipose tissue—Graves' disease	0.00125	0.0299	CbGeAlD
Nifedipine—Urticaria—Methimazole—Graves' disease	0.00121	0.0164	CcSEcCtD
Nifedipine—Body temperature increased—Methimazole—Graves' disease	0.00121	0.0164	CcSEcCtD
Nifedipine—CACNA1D—thyroid gland—Graves' disease	0.00121	0.0289	CbGeAlD
Nifedipine—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00118	0.016	CcSEcCtD
Nifedipine—ABCC3—adipose tissue—Graves' disease	0.00117	0.028	CbGeAlD
Nifedipine—Paraesthesia—Propylthiouracil—Graves' disease	0.00117	0.0158	CcSEcCtD
Nifedipine—Somnolence—Propylthiouracil—Graves' disease	0.00115	0.0156	CcSEcCtD
Nifedipine—CALM2—eye—Graves' disease	0.00114	0.0274	CbGeAlD
Nifedipine—Dyspepsia—Propylthiouracil—Graves' disease	0.00114	0.0155	CcSEcCtD
Nifedipine—CALM1—eye—Graves' disease	0.00114	0.0273	CbGeAlD
Nifedipine—CALM2—connective tissue—Graves' disease	0.0011	0.0264	CbGeAlD
Nifedipine—CALM1—connective tissue—Graves' disease	0.0011	0.0263	CbGeAlD
Nifedipine—CALM3—pituitary gland—Graves' disease	0.00108	0.0259	CbGeAlD
Nifedipine—Pruritus—Methimazole—Graves' disease	0.00108	0.0146	CcSEcCtD
Nifedipine—CALM3—adipose tissue—Graves' disease	0.00108	0.0258	CbGeAlD
Nifedipine—Urticaria—Propylthiouracil—Graves' disease	0.00103	0.014	CcSEcCtD
Nifedipine—Body temperature increased—Propylthiouracil—Graves' disease	0.00103	0.0139	CcSEcCtD
Nifedipine—ABCC3—thyroid gland—Graves' disease	0.00101	0.0242	CbGeAlD
Nifedipine—Vomiting—Methimazole—Graves' disease	0.000971	0.0132	CcSEcCtD
Nifedipine—Rash—Methimazole—Graves' disease	0.000963	0.013	CcSEcCtD
Nifedipine—Dermatitis—Methimazole—Graves' disease	0.000962	0.013	CcSEcCtD
Nifedipine—Headache—Methimazole—Graves' disease	0.000956	0.013	CcSEcCtD
Nifedipine—CALM3—thyroid gland—Graves' disease	0.000933	0.0223	CbGeAlD
Nifedipine—Pruritus—Propylthiouracil—Graves' disease	0.000918	0.0124	CcSEcCtD
Nifedipine—Nausea—Methimazole—Graves' disease	0.000907	0.0123	CcSEcCtD
Nifedipine—CALM2—pituitary gland—Graves' disease	0.00085	0.0203	CbGeAlD
Nifedipine—CALM2—adipose tissue—Graves' disease	0.000846	0.0202	CbGeAlD
Nifedipine—CALM1—pituitary gland—Graves' disease	0.000846	0.0202	CbGeAlD
Nifedipine—CALM1—adipose tissue—Graves' disease	0.000842	0.0201	CbGeAlD
Nifedipine—Vomiting—Propylthiouracil—Graves' disease	0.000825	0.0112	CcSEcCtD
Nifedipine—Rash—Propylthiouracil—Graves' disease	0.000819	0.0111	CcSEcCtD
Nifedipine—Dermatitis—Propylthiouracil—Graves' disease	0.000818	0.0111	CcSEcCtD
Nifedipine—Headache—Propylthiouracil—Graves' disease	0.000813	0.011	CcSEcCtD
Nifedipine—Nausea—Propylthiouracil—Graves' disease	0.000771	0.0105	CcSEcCtD
Nifedipine—CALM2—thyroid gland—Graves' disease	0.000732	0.0175	CbGeAlD
Nifedipine—CALM1—thyroid gland—Graves' disease	0.000729	0.0174	CbGeAlD
Nifedipine—CYP2C8—pituitary gland—Graves' disease	0.000704	0.0168	CbGeAlD
Nifedipine—CYP1A1—adipose tissue—Graves' disease	0.000647	0.0155	CbGeAlD
Nifedipine—CYP3A5—adipose tissue—Graves' disease	0.000633	0.0151	CbGeAlD
Nifedipine—CYP1A2—thyroid gland—Graves' disease	0.000568	0.0136	CbGeAlD
Nifedipine—CYP1A1—thyroid gland—Graves' disease	0.00056	0.0134	CbGeAlD
Nifedipine—CYP2E1—thyroid gland—Graves' disease	0.000511	0.0122	CbGeAlD
Nifedipine—ABCB1—pituitary gland—Graves' disease	0.000338	0.00808	CbGeAlD
Nifedipine—ABCB1—adipose tissue—Graves' disease	0.000336	0.00804	CbGeAlD
Nifedipine—ABCB1—thyroid gland—Graves' disease	0.000291	0.00696	CbGeAlD
